JP2008511668A5 - - Google Patents

Download PDF

Info

Publication number
JP2008511668A5
JP2008511668A5 JP2007530352A JP2007530352A JP2008511668A5 JP 2008511668 A5 JP2008511668 A5 JP 2008511668A5 JP 2007530352 A JP2007530352 A JP 2007530352A JP 2007530352 A JP2007530352 A JP 2007530352A JP 2008511668 A5 JP2008511668 A5 JP 2008511668A5
Authority
JP
Japan
Prior art keywords
methyl
imidazo
tetrahydro
pyridin
quinolinamine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007530352A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008511668A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/031098 external-priority patent/WO2006028896A2/en
Publication of JP2008511668A publication Critical patent/JP2008511668A/ja
Publication of JP2008511668A5 publication Critical patent/JP2008511668A5/ja
Pending legal-status Critical Current

Links

JP2007530352A 2004-09-02 2005-08-31 化合物 Pending JP2008511668A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US60674204P 2004-09-02 2004-09-02
US61076504P 2004-09-17 2004-09-17
PCT/US2005/031098 WO2006028896A2 (en) 2004-09-02 2005-08-31 Chemical compounds

Publications (2)

Publication Number Publication Date
JP2008511668A JP2008511668A (ja) 2008-04-17
JP2008511668A5 true JP2008511668A5 (enExample) 2008-10-16

Family

ID=36000724

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007530353A Pending JP2008511669A (ja) 2004-09-02 2005-08-28 化合物
JP2007530352A Pending JP2008511668A (ja) 2004-09-02 2005-08-31 化合物

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2007530353A Pending JP2008511669A (ja) 2004-09-02 2005-08-28 化合物

Country Status (16)

Country Link
US (2) US20070254910A1 (enExample)
EP (2) EP1799671A4 (enExample)
JP (2) JP2008511669A (enExample)
KR (2) KR20070049682A (enExample)
AR (2) AR051565A1 (enExample)
AU (2) AU2005279835A1 (enExample)
BR (1) BRPI0514881A (enExample)
CA (2) CA2579059A1 (enExample)
IL (1) IL181419A0 (enExample)
MA (1) MA28872B1 (enExample)
MX (2) MX2007002679A (enExample)
NO (2) NO20071366L (enExample)
PE (2) PE20060656A1 (enExample)
RU (2) RU2352567C2 (enExample)
TW (2) TW200621754A (enExample)
WO (2) WO2006026703A2 (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1799671A4 (en) * 2004-09-02 2009-06-10 Smithkline Beecham Corp CHEMICAL COMPOUNDS
US20100280010A1 (en) * 2006-01-25 2010-11-04 Kristjan Gudmundsson Chemical compounds
US8618122B2 (en) 2006-05-16 2013-12-31 Ono Pharmaceutical Co., Ltd. Compound having acidic group which may be protected, and use thereof
EP2055705A4 (en) 2006-07-31 2014-08-20 Ono Pharmaceutical Co COMPOUND WITH A CYCLIC GROUP BOUND BY A SPIRO BINDING THEREOF AND APPLY THEREOF
US7767826B2 (en) * 2007-10-05 2010-08-03 Pharmatech International, Inc. Process for the synthesis of L-(+)-ergothioneine
EP2217069A4 (en) * 2007-11-09 2012-03-14 Salk Inst For Biological Studi INHIBITORS OF NON-NUCLEOSIDE INHIBITORS OF THE REVERSE TRANSCRIPTASE
CN102675305B (zh) * 2011-03-08 2014-11-12 中国科学院上海药物研究所 一类咪唑并吡啶类化合物及其制备方法和用途
CN103570683B (zh) * 2012-07-30 2018-04-17 中国科学院上海药物研究所 多取代胺类化合物及其制备方法和用途
PT3105226T (pt) 2014-02-13 2019-11-06 Incyte Corp Ciclopropilaminas como inibidores de lsd1
ME03654B (me) 2014-02-13 2020-07-20 Incyte Corp Ciklopropilamini kao lsd1 inhibitori
WO2016007722A1 (en) 2014-07-10 2016-01-14 Incyte Corporation Triazolopyridines and triazolopyrazines as lsd1 inhibitors
AU2016243939B2 (en) * 2015-04-03 2020-09-03 Incyte Holdings Corporation Heterocyclic compounds as LSD1 inhibitors
KR102710120B1 (ko) 2015-08-12 2024-09-27 인사이트 홀딩스 코포레이션 Lsd1 저해제의 염
CA3008272A1 (en) 2015-12-14 2017-06-22 X4 Pharmaceuticals, Inc. Methods for treating cancer
CA3008279A1 (en) 2015-12-14 2017-06-22 X4 Pharmaceuticals, Inc. Methods for treating cancer
WO2017106291A1 (en) * 2015-12-15 2017-06-22 Bristol-Myers Squibb Company Cxcr4 receptor antagonists
EP3393468B1 (en) 2015-12-22 2022-09-14 X4 Pharmaceuticals, Inc. Methods for treating immunodeficiency disease
JP2019510785A (ja) 2016-04-08 2019-04-18 エックス４ ファーマシューティカルズ， インコーポレイテッド 癌を処置する方法
CA3027498A1 (en) 2016-06-21 2017-12-28 X4 Pharmaceuticals, Inc. Cxcr4 inhibitors and uses thereof
US10988465B2 (en) 2016-06-21 2021-04-27 X4 Pharmaceuticals, Inc. CXCR4 inhibitors and uses thereof
WO2017223243A1 (en) * 2016-06-21 2017-12-28 X4 Pharmaceuticals, Inc. Cxcr4 inhibitors and uses thereof
WO2018156595A1 (en) 2017-02-21 2018-08-30 Emory University Chemokine cxcr4 receptor modulators and uses related thereto
US11396501B2 (en) * 2017-09-25 2022-07-26 Cgenetech (Suzhou, China) Co., Ltd. Heteroaryl compounds as CXCR4 inhibitors, composition and method using the same
KR102678977B1 (ko) * 2017-09-25 2024-06-28 씨젠테크 (쑤저우, 차이나) 컴퍼니 리미티드 Cxcr4 저해제로서 헤테로아릴 화합물, 그 조성물 및 이용 방법
US11649235B2 (en) 2018-03-19 2023-05-16 Emory University Pan-tropic entry inhibitors
US10548889B1 (en) 2018-08-31 2020-02-04 X4 Pharmaceuticals, Inc. Compositions of CXCR4 inhibitors and methods of preparation and use
WO2020047198A1 (en) 2018-08-31 2020-03-05 Incyte Corporation Salts of an lsd1 inhibitor and processes for preparing the same
EP4117662A4 (en) 2020-03-10 2024-04-03 X4 Pharmaceuticals, Inc. METHODS OF TREATING NEUTROPENIA

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ225152A (en) * 1987-07-17 1990-04-26 Janssen Pharmaceutica Nv Heterocyclically substituted piperidinyl benzamides as pharmaceuticals
EP1317445B1 (en) * 2000-09-15 2009-03-11 Anormed Inc. Chemokine receptor binding heterocyclic compounds
BR0113932A (pt) * 2000-09-15 2003-06-24 Anormed Inc Compostos heterocìclicos que se ligam ao receptor da quimiocina
JP2004512336A (ja) * 2000-09-15 2004-04-22 アノーメッド　インコーポレイティド ケモカインレセプター結合複素環式化合物
SG126006A1 (en) * 2000-09-15 2006-10-30 Anormed Inc Chemokine receptor binding heterocyclic compounds
CN1596255A (zh) * 2001-12-21 2005-03-16 阿诺麦德股份有限公司 具有强效的与趋化因子受体结合的杂环化合物
EP1613613B1 (en) * 2003-04-11 2021-06-02 Genzyme Corporation Cxcr4 chemokine receptor binding compounds
EP1799671A4 (en) * 2004-09-02 2009-06-10 Smithkline Beecham Corp CHEMICAL COMPOUNDS
JP2008514622A (ja) * 2004-09-24 2008-05-08 スミスクライン ビーチャム コーポレーション 化合物
JP2009507795A (ja) * 2005-08-31 2009-02-26 スミスクライン ビーチャム コーポレーション 化合物

Similar Documents

Publication Publication Date Title
JP2008511668A5 (enExample)
RU2351592C2 (ru) Производные тетрагидрохинолина и фармацевтическая композиция на их основе для лечения и профилактики вич-инфекции
JP2008510006A5 (enExample)
JP2008511669A5 (enExample)
RU2632900C2 (ru) Гетероциклические амины и их применение
CA2228370C (en) Piperazino derivatives as neurokinin antagonists
RU2486188C2 (ru) СОЕДИНЕНИЯ ИМИДАЗО-[1,2-b]-ПИРИДАЗИНА (ВАРИАНТЫ), СПОСОБ ПОЛУЧЕНИЯ СОЕДИНЕНИЙ ИМИДАЗО-[1,2-b]-ПИРИДАЗИНА (ВАРИАНТЫ), ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ И ЛЕКАРСТВЕННОЕ СРЕДСТВО ДЛЯ ЛЕЧЕНИЯ И/ИЛИ ПРЕДУПРЕЖДЕНИЯ ЗАБОЛЕВАНИЙ, СВЯЗАННЫХ С ИНГИБИРОВАНИЕМ ГАМКА РЕЦЕПТОРОВ
RU2004117156A (ru) Амид замещенные имидазопиридины
RS60312B1 (sr) Jedinjenja indol karboksamida korisna kao inhibitori kinaze
US20030191143A1 (en) Fused heterocyclic compounds and use thereof
TW201819386A (zh) Shp2磷酸酶抑制劑及其使用方法
RU2015106787A (ru) Замещенные пирролы, активные в качестве ингибиторов киназ
RU2004106783A (ru) Производные 4-амино-6-фенилпирроло[2, 3] пиримидина
JP2005511745A5 (enExample)
JP2008525502A (ja) 抗炎症薬
JP2004511483A (ja) Ｈｉｖインテグラーゼ阻害薬として有用なアザ−およびポリアザ−ナフタレニルカルボキサミド類
CN103936690A (zh) 氨基二氢噻嗪衍生物
JP2009529047A5 (enExample)
RU2005136130A (ru) Новые антагонисты р2х7 рецепторов и их применение
JP2003300959A5 (enExample)
JP2008509187A5 (enExample)
JP2005524609A5 (enExample)
TW201225957A (en) Glycine transporter inhibitor
RS59707B1 (sr) Derivati karbazola
JP2023529099A (ja) 修飾タンパク質およびタンパク質分解誘導薬